Shopping Cart 0
Cart Subtotal
USD 0

Pascal Biosciences Inc (PAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body's own immune system to recognize and attack cancers, infections and autoimmune diseases. It advances research programs such as developing a therapeutic monoclonal antibody for treatment of b-cell precursor acute lymphoblastic leukemia; optimizing novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company also conducts research on calcium channel blockers that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection. Pascal Biosciences is headquartered in Vancouver, British Columbia, Canada.

Pascal Biosciences Inc (PAS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Biommune Enters into Agreement with University of British Columbia 10

Licensing Agreements 11

Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11

Equity Offering 12

Pascal Biosciences Increases Size of Private Placement of Units for USD4 Million 12

Pascal Biosciences to Raise up to USD0.1 Million in Private Placement of Units 13

BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 14

BioMmune Raise USD0.8 Million in Private Placement of Units 15

Acquisition 16

MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 16

Pascal Biosciences Inc-Key Competitors 17

Pascal Biosciences Inc-Key Employees 18

Pascal Biosciences Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Strategy And Business Planning 20

May 09, 2017: Pascal Biosciences Creates Development Science Lab in Seattle WA 20

Corporate Communications 21

Jul 16, 2018: Pascal Biosciences names Julie M. Eastland as board director 21

Dec 05, 2017: Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell 22

Legal and Regulatory 23

Jun 18, 2018: Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration 23

Product News 24

Feb 21, 2018: Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells 24

Other Significant Developments 25

Mar 30, 2017: bioMmune Announces Name Change to Pascal Biosciences 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pascal Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Biommune Enters into Agreement with University of British Columbia 10

Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11

Pascal Biosciences Increases Size of Private Placement of Units for USD4 Million 12

Pascal Biosciences to Raise up to USD0.1 Million in Private Placement of Units 13

BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 14

BioMmune Raise USD0.8 Million in Private Placement of Units 15

MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 16

Pascal Biosciences Inc, Key Competitors 17

Pascal Biosciences Inc, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Pascal Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body's own immune system to recognize and attack cancers, infections and autoimmune diseases. It advances research programs such as developing a therapeutic monoclonal antibody for treatment of b-cell precursor acute lymphoblastic leukemia; optimizing novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company also conducts research on calcium channel blockers that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection. Pascal Biosciences is headquartered in Vancouver, British Columbia, Canada.

Pascal Biosciences Inc (PAS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Biommune Enters into Agreement with University of British Columbia 10

Licensing Agreements 11

Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11

Equity Offering 12

Pascal Biosciences Increases Size of Private Placement of Units for USD4 Million 12

Pascal Biosciences to Raise up to USD0.1 Million in Private Placement of Units 13

BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 14

BioMmune Raise USD0.8 Million in Private Placement of Units 15

Acquisition 16

MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 16

Pascal Biosciences Inc-Key Competitors 17

Pascal Biosciences Inc-Key Employees 18

Pascal Biosciences Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Strategy And Business Planning 20

May 09, 2017: Pascal Biosciences Creates Development Science Lab in Seattle WA 20

Corporate Communications 21

Jul 16, 2018: Pascal Biosciences names Julie M. Eastland as board director 21

Dec 05, 2017: Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell 22

Legal and Regulatory 23

Jun 18, 2018: Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration 23

Product News 24

Feb 21, 2018: Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells 24

Other Significant Developments 25

Mar 30, 2017: bioMmune Announces Name Change to Pascal Biosciences 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pascal Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Biommune Enters into Agreement with University of British Columbia 10

Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11

Pascal Biosciences Increases Size of Private Placement of Units for USD4 Million 12

Pascal Biosciences to Raise up to USD0.1 Million in Private Placement of Units 13

BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 14

BioMmune Raise USD0.8 Million in Private Placement of Units 15

MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 16

Pascal Biosciences Inc, Key Competitors 17

Pascal Biosciences Inc, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Pascal Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.